drugset / Trial / NCT04041765

IgM-Enriched Immunoglobulin for Neonatal Sepsis

NCT04041765

Phase 3 Unknown 70 enrolled Faculty of Medicine, University of Indonesia
RandomizedParallel-groupTriple-blindPrevention

Summary

This study compares giving prophylactic IgM enriched Intravenous Immunoglobulin (IVIG) with placebo in 1 hour after birth, in neonates with risk factors of Early-Onset Neonatal Sepsis (EONS). In addition to the intervention, standard regimen antibiotics are also given within 1 hour. The IVIG is given for 3 days and primary and secondary outcomes will be collected. Risk factors are both from maternal and neonate origin.

Timeline

Start
2019-09
Primary completion
2020-06
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentaglobin Protein / enzyme biologic 0.25 g/kg Intravenous

Indications